Skip to main content
. 2023 Feb 3;25(7):1286–1298. doi: 10.1093/neuonc/noad030

Table 2.

Multivariable analysis of progression-free survival for EPN-PFB tumors

P HR 95% CI
Age at diagnosis .998 1.00 0.95-1.05
Sex (female vs. male) .433 1.61 0.49-5.32
WHO tumor grade (grade 3 vs. grade 2) .087 7.89 0.74-84.24
1q gain (yes vs. no) .159 2.14 0.74-6.16
13q loss (yes vs. no) .260 2.07 0.58-7.31
Extent of resection (subtotal vs. gross total resection) .003* 5.92 1.84-19.03
Postoperative radiotherapy (no vs. yes) .007* 21.26 2.29-197.25

Abbreviations:

* P-value ≤.05, HR = hazard ratio, CI = confidence interval.